| Bioactivity | Maytansine derivative M24 is an ADC Drug-Linker Conjugates for ADC that can be used to synthesize ADC REGN5093-M114[1]. |
| CAS | 2226467-81-6 |
| Formula | C61H86ClN9O18 |
| Molar Mass | 1268.84 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Drilon A, et al. EP10. 01-03 A Phase 1/2 Study of REGN5093-M114, a METxMET Antibody-Drug Conjugate, in Patients with MET-Overexpressing NSCLC. Journal of Thoracic Oncology, 2023, 18(11): S602-S603. |
Maytansine derivative M24
CAS: 2226467-81-6 F: C61H86ClN9O18 W: 1268.84
Maytansine derivative M24 is an ADC Drug-Linker Conjugates for ADC that can be used to synthesize ADC REGN5093-M114.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.